Rensheng M. Wang
6 Shuangyong Road
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Efficacy and safety analysis of PD-1 inhibitors combined with chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma.
Journal: Frontiers in immunology
Published: May 08, 2026
ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma.
Journal: Human mutation
Published: January 06, 2026
IGFBP2 promotes immunosuppression by regulating macrophage PD-L1 expression in NEUROD1-high small cell lung cancer.
Journal: Journal of translational medicine
Published: November 13, 2025
The effects of vitamin D combined with thermotherapy and resistance exercise on inflammatory factors, thyroid hormones and MSTN in elderly patients with sarcopenia.
Journal: Pakistan journal of pharmaceutical sciences
Published: October 26, 2025
Dosimetric Comparison of Intracavitary Versus Combined Intracavitary-Interstitial Image-Guided Brachytherapy in Locally Advanced Cervical Cancer.
Journal: Dose-response : a publication of International Hormesis Society
Published: October 16, 2025
Evaluating the potential causal relationship between carnitine-related metabolites and breast cancer: a Mendelian randomization and transcriptomic analysis.
Journal: Archives of medical science : AMS
Published: October 16, 2025
Efficacy of PD-1 inhibitor plus induction chemotherapy for nasopharyngeal carcinoma with high-grade extranodal extension: a multicenter retrospective analysis.
Journal: BMC cancer
Published: September 17, 2025
Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial.
Journal: Frontiers in immunology
Published: August 17, 2025
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.
Journal: Signal transduction and targeted therapy
Published: August 12, 2025
A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1/PRDX1 as therapeutic targets.
Journal: Frontiers in immunology
Published: July 31, 2025
Last Updated: 09/26/2026